Fluorescence Imaging Device Aids Wound Treatment
By MedImaging International staff writers Posted on 22 Aug 2018 |
Image: The MolecuLight i:X handheld device uses fluorescence imaging to identify bacteria (Photo courtesy of MolecuLight).
A novel wound imaging device digitally captures and documents fluorescence information from wounds and surrounding tissue using still images and videos in real-time.
The MolecuLight (Toronto, Canada) MolecuLight i:X is intended for point of care (POC) visualization and quantitative tracking of bacterial contamination, wound healing, and connective tissue remodeling of surgical sites and wounds, based on the detection of intrinsic fluorescence signals emitted by tissues and microbes when illuminated with specific wavelengths of light, without the need of contrast agents. Images can be captured and documented as either still images or videos of wounds, including in the surrounding areas where potentially harmful bacteria may be lurking.
MolecuLight i:X emits a precise wavelength of safe violet light, which interacts with the wound tissue and bacteria causing the wound and surrounding skin to emit a green fluorescence, while potentially harmful bacteria emit a red fluorescence. The device captures these red and green fluorescence signals in real time using specialized optical components to filter out the violet light, displaying the resultant image immediately on-screen. The MolecuLight i:X is precisely calibrated to detect fluorescent bacteria at levels higher than 104 CFU/g on a quantitative scale, or predominantly moderate to heavy growth on a semi-quantitative scale.
MolecuLight i:X illuminates the wound with a narrow band of violet light that causes endogenous fluorophores in the bacteria to fluoresce. Susceptible bacteria include Staphylocccus aureus and MRSA; Pseudomonas aeruginosa; Escherichia coli; Coagulase-negative staphylococci; multiple Enterococcus species; multiple Proteus species; Klebsiella pneumonia; Beta-hemolytic streptococci (Group B); and multiple Enterobacter species. It is recommended that imaging be performed after surface blood has been removed from the wound bed and peri-wound areas.
“The MolecuLight i:X platform is a significant advancement in the management of chronic wounds that is already revolutionizing wound care practice in Canada and Europe,” said Ralph DaCosta, PhD, founder, director, and chief scientific officer of MolecuLight. “Thousands of patients have already experienced a change in their assessment and treatment by clinicians who feel empowered by the wound fluorescence images they are seeing.”
Related Links:
MolecuLight
The MolecuLight (Toronto, Canada) MolecuLight i:X is intended for point of care (POC) visualization and quantitative tracking of bacterial contamination, wound healing, and connective tissue remodeling of surgical sites and wounds, based on the detection of intrinsic fluorescence signals emitted by tissues and microbes when illuminated with specific wavelengths of light, without the need of contrast agents. Images can be captured and documented as either still images or videos of wounds, including in the surrounding areas where potentially harmful bacteria may be lurking.
MolecuLight i:X emits a precise wavelength of safe violet light, which interacts with the wound tissue and bacteria causing the wound and surrounding skin to emit a green fluorescence, while potentially harmful bacteria emit a red fluorescence. The device captures these red and green fluorescence signals in real time using specialized optical components to filter out the violet light, displaying the resultant image immediately on-screen. The MolecuLight i:X is precisely calibrated to detect fluorescent bacteria at levels higher than 104 CFU/g on a quantitative scale, or predominantly moderate to heavy growth on a semi-quantitative scale.
MolecuLight i:X illuminates the wound with a narrow band of violet light that causes endogenous fluorophores in the bacteria to fluoresce. Susceptible bacteria include Staphylocccus aureus and MRSA; Pseudomonas aeruginosa; Escherichia coli; Coagulase-negative staphylococci; multiple Enterococcus species; multiple Proteus species; Klebsiella pneumonia; Beta-hemolytic streptococci (Group B); and multiple Enterobacter species. It is recommended that imaging be performed after surface blood has been removed from the wound bed and peri-wound areas.
“The MolecuLight i:X platform is a significant advancement in the management of chronic wounds that is already revolutionizing wound care practice in Canada and Europe,” said Ralph DaCosta, PhD, founder, director, and chief scientific officer of MolecuLight. “Thousands of patients have already experienced a change in their assessment and treatment by clinicians who feel empowered by the wound fluorescence images they are seeing.”
Related Links:
MolecuLight
Latest General/Advanced Imaging News
- PET Scans Reveal Hidden Inflammation in Multiple Sclerosis Patients
- Artificial Intelligence Evaluates Cardiovascular Risk from CT Scans
- New AI Method Captures Uncertainty in Medical Images
- CT Coronary Angiography Reduces Need for Invasive Tests to Diagnose Coronary Artery Disease
- Novel Blood Test Could Reduce Need for PET Imaging of Patients with Alzheimer’s
- CT-Based Deep Learning Algorithm Accurately Differentiates Benign From Malignant Vertebral Fractures
- Minimally Invasive Procedure Could Help Patients Avoid Thyroid Surgery
- Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery
- AR Application Turns Medical Scans Into Holograms for Assistance in Surgical Planning
- Imaging Technology Provides Ground-Breaking New Approach for Diagnosing and Treating Bowel Cancer
- CT Coronary Calcium Scoring Predicts Heart Attacks and Strokes
- AI Model Detects 90% of Lymphatic Cancer Cases from PET and CT Images
- Breakthrough Technology Revolutionizes Breast Imaging
- State-Of-The-Art System Enhances Accuracy of Image-Guided Diagnostic and Interventional Procedures
- Catheter-Based Device with New Cardiovascular Imaging Approach Offers Unprecedented View of Dangerous Plaques
- AI Model Draws Maps to Accurately Identify Tumors and Diseases in Medical Images